On
December 1st, 2001, the Canadian government started stockpiling
smallpox vaccine. On June 21st, 2002 the National Vaccine Information
Center, the oldest vaccine safety organization in the U.S. endorsed the decision
by the Centers for Disease Control (CDC) to immunize health care workers against
smallpox as the first line of defense against a possible bio-terrorism attack.
Many other countries are following suit by either stockpiling vaccine or
starting mass-vaccination campaigns. However, some experts against the vaccine
are asking if forced, mass vaccination is just another form of terrorism. They
point out that although the idea of mass preventative vaccination may sound
reassuring that smallpox vaccines are known to have a very high risk factor,
causing disability, smallpox or even death and the vaccines have a high cost to
the public. Supporters of mass vaccination state that stockpiles of smallpox
vaccine would help prevent large numbers of deaths in the case of an outbreak.
However, they do not provide answers to the questions posed by experts against
the vaccine campaign.
Vaccine
advocates point out that in 18th century England, smallpox was the
cause of one in ten deaths and was only eradicated from the earth in 1979 after
worldwide immunization campaigns. Since then the smallpox virus has been
isolated to a few labs in the U.S.A. and Russia. However, recent events have
triggered the fear that countries hostile to the U.S. could have purchased some
of the virus for use in biological weapons and perhaps even genetically altered
it to create a more effective weapon (Kaplan).
The
first question set forth by cautionaries, however, is the motivation behind the
vaccine itself. Barbara Loe Fisher of the National Vaccine Information Center (NVIC)
wonders if mass forced vaccinations are just another indication that the
terrorists have won by inducing mass fear in the American public. Other experts
in the field point out that stockpiling small pox vaccine sets a dangerous
standard for future anti-terrorism policies. If the government decides to
stockpile smallpox vaccine then they must also agree to stockpile other vaccines
when they become available - vaccines such as the AIDS or anthrax vaccines.
Fisher points out that forced vaccination also poses many constitutional
problems. She says, "Even in the event of a proven biological weapons
assault and smallpox outbreak, sacrifice of the informed consent ethic would
result in state-forced vaccine-induced injury and death of a biologically
vulnerable minority in service to the majority, posing serious constitutional
and moral questions” (Fisher).
The
second problem with mass vaccination is the issue of how effective or even
needed the procedure would really be. There is actually a window up to four days
in which to vaccinate a person after they are exposed to the virus, meaning that
mass pre-vaccination is not really necessary. Furthermore, whereas smallpox used
to kill up to 30% of those infected, recent medical advances could bring that
down to 2% - the same rate of death from the common flu (Fisher). Another
concern over the effectiveness of the vaccine is over the disease itself. Some
doctors fear that bioterrorists could have altered the disease to make it more
lethal, thus rendering all current vaccinations useless against the new disease
(NVIC).
The
third question raised by the stockpiling of smallpox vaccine is how safe the
vaccine really is. A new study claims that the current U.S. strategy for
containing a deliberate release of smallpox could lead to tens of thousands of
unnecessary deaths (Kaplan). The policy - to trace, vaccinate and quarantine all
those infected and exposed - would be too little and take too long to protect a
large metropolitan area such as New York. Advocates state that the mass
immunization technique was the one that successfully controlled wild smallpox
outbreaks in cities in the last century. However, other organizations say that
even a mass immunization would be dangerous as the vaccine itself carries a high
risk factor. In fact, in evaluating the potential risk of a bioterrorism attack
with real, as well as unpredictable, risks of exposing large numbers of children
and adults to a prophylactic mass vaccination program for smallpox, some health
officials have already concluded that the risks of mass vaccination outweigh the
theoretical benefits (NVIC). This is because the live virus vaccine causes
reactions in almost everyone who gets it and causes life-threatening reactions
in 1 in 4000 people. The vaccine virus can also help spread the disease from one
person to another and up to 50% of the US population have health problems that
put them at high risk of injury if they take the vaccine. The vaccine is
especially dangerous to people who have a history of eczema or dermatitis. The
original smallpox vaccine invented by Jenner used cowpox as a vaccine, while the
modern version uses a live mixed virus that has a wide range of host
possibilities. The modern vaccine was never tested while the original one was (NVIC).
The
fourth question raised by the recent approved proposal is if the vaccination
campaign would actually create a problem where none now exists. Even though CDC
experts continue to insist the theoretical probability of the eradicated virus
being intentionally released is "very low”, they are, at the same time
releasing the vaccine itself into the general population. Just the vaccination
of the proposed 200,000-500,000 healthcare workers could spread the virus itself
to some of the most vulnerable people in the world – those who are being
treated at hospitals (NVIC). The NVIC says, “Because live vaccinia virus
vaccine can cause vaccinia viral infection in the vaccine recipient or in a
close contact of the recently vaccinated person, those who get vaccinated will
be exposing themselves and others to the vaccinia virus and potential
complications” (NVIC).
The
fifth question raised by the smallpox campaign is the cost of the campaign
itself. The Bush administration has finalized a $428 million deal to expand its
stockpile of smallpox vaccine so that it has some 286 million doses on hand by
the end of next year (CNN). Future cost estimates bring the total
predicted cost of the vaccine to nearly two billion, not counting the high cost
of administering the vaccine itself or the legal costs involved in dealing with
any vaccine reactions that may occur.
Last,
but not least, the administration of such a vaccine campaign poses many risks in
itself. Entire bottles of vaccines or batches of vaccines make good targets for
terrorists who may want to taint bottles of vaccine with poison. A tool of this
kind could be used against the general American public or could even be directed
against a hand-picked group of people such as a religious organization or ethnic
group who would all use one facility to vaccinate (Fisher). Secondly, at the
time vaccination became necessary panic may ensue unless the government creates
thousands of new sites and hires thousands of people capable of administering
the vaccine. Under the right circumstances long lines to vaccination facilities
could create the auctioning off of ones place in line, thus creating great
opportunity for coercion of the general public. In short, any campaign born out
of fear instead of faith has little chance of success. As it says in the Qur'an,
"And warn with it those who fear that they shall be gathered to their
Lord-- there is no guardian for them, nor any intercessor besides Him-- that
they may guard” (Qur'an 6:51).
[5.52]
But you will see those in whose hearts is a disease hastening towards them,
saying: We fear lest a calamity should befall us; but it may be that Allah will
bring the victory or a punishment from Himself, so that they shall be regretting
on account of what they hid in their souls.
Sources:
-
CNN.
Administration
to Buy Smallpox Vaccine. November 29, 2001.
-
Clarke,
Tom. Nature News
Service. Macmillan Press. July 10, 2002.
-
Harper,
Tim. “The
Rock Collects Vaccines.“ Dec. 1, 2001. The Star Online.
-
Kaplan,
E. H., Craft, D. L. & Wein, L. M. “Emergency response to a smallpox
attack: The case for mass vaccination.” Proceedings
of the National Academy of Sciences, (2002).
-
Fisher,
Barabra Loe. “Statement
on the CDC Plan to Release Smallpox Vaccine.” National Vaccine
Information Center. June 24, 2002.
-
NVIC
“Smallpox Vaccine and Mass Immunization.” National Vaccine Information
Center. 2002.